Although we clearly demonstrated that NOD1 activation increases the migratory phenotype of colon cancer cells in vitro, we sought to confirm its role in promoting a metastatic phenotype in a more physiologically relevant in vivo model. This evidence concerns the gene NOD1 and colonic neoplasm.